Veterinary Renal Disease Market

Veterinary Renal Disease Market - By Type (Treatment, Diagnosis), Animal (Bovine, Canine, Feline, Equine), Indication (Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis), Global Forecast (2024 – 2032)

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Free Sample Ask for Discount Request Customization

Veterinary Renal Disease Market Size

Veterinary Renal Disease Market size was USD 15.9 billion in 2023 and is expected to increase to USD 26.5 billion by 2032, growing at the rate of 5.9% from 2024 to 2032 timeframe. Market growth is due to various factors including increases in pet ownership and development of animal diagnostics.

To get key market trends

  Download Free Sample

In addition, growing incidence of renal disease in animals, increasing interest in animals' renoprotective diets, and rising awareness among pet owners as well as veterinarians are likely to spur the market growth. As per the report given by the International Renal Interest Society in 2023, the incidence of CKD is projected to be 0.5-1% in dogs and 1-3% in cats. But it is growing with age, particularly among cats whose reported prevalence is 80% in geriatric cat population. Adoption of treatment and diagnosis of renal disease in such population will drive the market growth.

Veterinary renal disease is any disease or condition of the animal kidney, including companion animals and livestock. These diseases can include structural abnormalities, functional disturbances, or inflammatory conditions of the kidney, causing the kidney to fail and causing subsequent complication in other organ systems.

Veterinary Renal Disease Market Report Attributes
Report Attribute Details
Base Year 2023
Veterinary Renal Disease Market Size in 2023 USD 15.9 Billion
Forecast Period 2024 - 2032
Forecast Period 2024 - 2032 CAGR 5.9%
2032 Value Projection USD 26.5 Billion
Historical Data for 2018 - 2023
No. of Pages 210
Tables, Charts & Figures 368
Segments covered Type, Animal Type, Indication, and Region
Growth Drivers
  • Advancements in veterinary medicine
  • Increasing prevalence of renal diseases in companion animals
  • Growing awareness among pet owners and veterinarians
  • Rising demand for renoprotective diets
Pitfalls & Challenges
  • Off-label use of drugs in veterinary treatment

What are the growth opportunities in this market?

 Download Free Sample

Veterinary Renal Disease Market Trends

  • Increasing pet ownership trend has led to a greater demand for veterinary services and products aimed at addressing the health needs of pets, including the diagnosis, treatment, and management of renal disease. This trend is expected to continue driving growth in the market.
  • Moreover, pet owners are increasingly willing to invest in diagnostic testing to ensure the early detection and management of health conditions in their pets. This includes routine bloodwork, urinalysis, and imaging studies such as ultrasound, which can aid in the early diagnosis of renal disease among pets. Thus, the growing demand for diagnostic testing fuels the growth of the market.

Veterinary Renal Disease Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

The market based on type is segmented into treatment and diagnosis. The treatment segment accounted for majority of market share of 67.3% in 2023 and is expected to dominate throughout the analysis period.

  • The segmental growth is because of the increasing incidence of kidney conditions in animals, which raises the demand for efficient cure solutions. Further, the need measures to treat and mitigate renal ailments in animals are also on a rise with more and more animals getting diagnosed.
  • Additionally, the veterinarians possess a vast array of equipment to treat various steps and types of renal impairments in animals. Thus, the preventive and proactive healthcare emphasizes the importance of treatment products, thus fueling the segment growth.

Learn more about the key segments shaping this market

 Download Free Sample

The veterinary kidney disease on the basis of animal type is categorized into bovine, canine, feline, equine, and other types of animals. The feline type of animal led the market and held a value of USD 6.7 billion in 2023.

Chronic kidney disease is a common disease in older cats, and its prevalence is increasing. The trend is pushing demand for feline CKD diagnostic tests, treatments, and management procedures. All of these factors combine to make cats have the highest incidence of veterinary renal disease among dogs, horses, and cows.

For example, based on statistics released by American Veterinary Medical Association in 2021, chronic kidney disease (CKD) in cats varied from 2% - 20%. In cats aged over 10 - 15 years, this figure increase up to 30% - 80%. Therefore, increased incidence of CKD in cats coupled with increased focus on early diagnosis is expected to drive the market growth.

Based on indication, the veterinary renal disease market is divided into renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, and other indications. The renal cystitis segment accounted for significant market position and is predicted to reach USD 7.5 billion by 2032.

  • Renal cystitis is an inflammation of urinary bladder that is prevalent and identifiable indicator since it occur recurrently with or preceding other renal illnesses. Hence, rising incidence of renal cystitis is one the key factor fuelling market growth.
  • Additionally, cystitis infection may go on to manifest other complications related to the kidneys and go further to become pyelonephritis. Further, renal cystitis is linked with infections from bacteria that travel from the lower urinary tract to affect the kidneys. Therefore, the interaction of these factors cumulatively contributes to the growth of this segment.

Looking for region specific data?

 Download Free Sample

North America veterinary renal disease market accounted for USD 7 billion revenue in 2023 and is anticipated to grow at CAGR of 5.7% between 2024 and 2032 period.

  • An important factor contributing to market expansion is the increasing emphasis on comprehensive animal healthcare throughout the region. As per data from the American Pet Products Association, there were 65.1 million households in the U.S. owning pets during 2023-24. Thus, adoption of pet-owning households underscores the increasing emphasis on holistic animal healthcare, serving as a significant factor propelling the market expansion in the region.
  • Further, presence of key players, increasing R&D activities along with growing awareness pertaining to early diagnosis of renal diseases among animals will supplement the market growth.

Veterinary Renal Disease Market Share

The veterinary renal disease industry is characterized by the presence of several key players offering innovative solutions to healthcare providers. Leading companies in this market include Boehringer Ingelheim International GmbH, Zoetis Inc., and Elanco Animal Health Incorporated, among others. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.

Veterinary Renal Disease Market Companies

Prominent players operating in the veterinary renal disease industry include

Veterinary Renal Disease Industry News

  • In January 2024, Zoetis Inc. expanded its Vetscan Imagyst multi-application diagnostics platform by introducing AI Urine Sediment analysis. This new application utilizes deep learning artificial intelligence to provide accurate in-clinic sediment analysis of fresh urine for quick treatment decisions by veterinarians. The AI technology ensures consistent and precise results within minutes, enhancing the efficiency of individualized treatment plans for pets and pet owners, thereby strengthening its business segment.
  • In June 2023, IDEXX Laboratories, Inc. introduced the IDEXX Cystatin B Test, the first veterinary diagnostic test designed to detect kidney injury in dogs and cats. This innovative test is included in panels assessing renal health. IDEXX plans to expand the test to Europe by 2024. This new addition to IDEXX's renal testing portfolio helps company to enhance their product offerings.

The veterinary renal disease market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 - 2032 for the following segments

Click here to Buy Section of this Report

Market, By Type

  • Treatment
    • Drugs
      • By drug type
        • NSAIDs
        • Antibiotics
        • Cystine-binding agents
        • Diuretics
        • Other drugs
      • By route of administration
        • Oral
        • Injectable
      • By distribution channel
        • Pharmacies
        • Pet specialty stores
        • E-commerce
        • Other distribution channels
    • Food supplements
  • Diagnosis
    • Test kits & consumables
    • Instruments

Market, By Animal Type

  • Bovine
  • Canine
  • Feline
  • Equine
  • Other animal types

Market, By Indications

  • Renal failure
  • Chronic kidney disease (CKD)
  • Renal cystitis
  • Kidney stones
  • Nephritis
  • Other indications

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East and Africa

 

Related Reports

Table of Content

  1. Executive Summary

    • Overview of the Veterinary Renal Disease Market

    • Key Findings

    • Market Outlook

  2. Market Introduction

    • Definition and Scope

    • Disease Overview: Renal Disorders in Animals

    • Importance of Early Diagnosis and Treatment

  3. Market Dynamics

    • Drivers

    • Restraints

    • Opportunities

    • Challenges

    • Regulatory Landscape

  4. Market Segmentation

    • By Animal Type

      • Companion Animals (Dogs, Cats)

      • Livestock

    • By Product Type

      • Therapeutics

      • Diagnostics

      • Renal Supplements

      • Dialysis Equipment

    • By End-User

      • Veterinary Hospitals

      • Veterinary Clinics

      • Research Institutes

  5. Regional Analysis

    • North America

    • Europe

    • Asia-Pacific

    • Latin America

    • Middle East & Africa

  6. Competitive Landscape

    • Company Profiles

    • Key Players & Market Share

    • Recent Developments

    • Strategic Initiatives

  7. Technological Advancements

    • Innovations in Diagnostic Tools

    • Emerging Treatments and Therapies

    • Role of AI and Telemedicine

  8. Market Trends & Future Outlook

    • Demand Forecast (2024–2030)

    • Emerging Trends

    • Investment Opportunities

  9. Conclusion

    • Summary of Key Insights

    • Strategic Recommendations

  10. Appendix

  • Glossary

  • Research Methodology

  • Data Sources

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email